The Medical Technology Enterprise Consortium award will support Fitbit’s ongoing work as well as help the company start a study of the tech alongside New Hyde Park, N.Y.-based Northwell Health’s Feinstein Institutes for Medical Research.
The study aims to validate a Fitbit COVID-19 early detection algorithm, and as part of the initiative, Fitbit will distribute thousands of wearable devices to Northwell employees. The individuals will then be notified of potential illness and be tested for COVID-19 to assess and verify results.
The study builds upon Fitbit’s work in COVID-19 research, which includes a collaborative research consortium with the Scripps Research Institute and Stanford (Calif.) Medicine that launched earlier this year. As part of the initiative, Fitbit is conducting a study to determine whether it can create an algorithm to detect COVID-19 before symptoms start; early findings show that the algorithm can identify almost 50 percent of COVID-19 cases before users report having symptoms with nearly 70 percent specificity.
More articles on digital transformation:
Baylor Scott & White deploys concussion test app to sidelines for student athletes
Intuitive launches $100M VC fund: 4 details
Moda Health teams up with Fitbit to offer health trackers to 64,000+ members
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
